Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 59
Hot Topic Symposia

Endocrinology

Neonatology

Neurology

Trainee
Session Type: Hot Topic Symposia

Hyperglycemia and outcomes after neonatal encephalopathy

Sunday, May 5, 2024
8:00 AM – 9:30 AM ET
Location: Metro Toronto Convention Centre: 104 CD
CE: Live CME: 1.5

Selected By: CNS
Co-sponsored By: Neonatal, NBS
Disclosure(s):
Emily WY Tam, MDCM, MAS, FRCPC: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Paolo Montaldo, Md, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: WIth high incidence of hyperglycemia in neonatal encephalopathy, the potential contributions of abnormal blood sugars to hypoxic-ischemic brain injury and long-term outcomes has become an important clinical question. This symposium brings together pre-clinical and clinical research, neurology, neonatology, and endocrinology to discuss the latest research regarding the contributions of hyperglycemia to brain dysfunction, injury, and outcomes in animal and human studies. Incorporating endocrinological considerations regarding glucose metabolism and management in the context of neonatal hypoxia-ischemia, future directions in regards to glucose management in neonatal encephalopathy will be discussed.

Learning Objectives:

  • Understand the pre-clinical evidence for the contribution of hyperglycemia to brain injury in neonatal hypoxia-ischemia.
  • Understand the latest clinical research regarding how hyperglycemia in neonatal encephalopathy is associated with acute neurophysiological changes, brain injury, and long-term neurodevelopmental outcomes.
  • Understand the metabolic and endocrinological considerations that dictate next steps in glucose management in neonatal encephalopathy.

Presentations:

  • 8:00 AM – 8:20 AM ET
    Pre-clinical studies of brain injury after hyperglycemia in neonatal encephalopathy

    Speaker: Susan S. Cohen, MD (she/her/hers) – Medical College of Wisconsin

  • 8:20 AM – 8:40 AM ET
    Clinical studies of brain injury after hyperglycemia in neonatal encephalopathy

    Speaker: Emily WY Tam, MDCM, MAS, FRCPC (she/her/hers) – University of Toronto

  • 8:40 AM – 9:00 AM ET
    Glucose metabolism and treatment considerations in neonatal encephalopathy

    Speaker: Elizabeth Rosenfeld, MD (she/her/hers) – Children's Hospital of Philadelphia

  • 9:00 AM – 9:10 AM ET
    Next steps towards management of hyperglycemia in neonatal encephalopathy

    Speaker: Paolo Montaldo, Md, PhD (he/him/his) – Imperial College London